Literature DB >> 9232430

The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient.

C Kolb1, S Mauch, H H Peter, U Krawinkel, R Sedlacek.   

Abstract

RASI-1 is a novel matrix metalloproteinase which we isolated from an expression cDNA library representing the mRNA of an inflamed synovium obtained from a patient with rheumatoid arthritis (RA). To investigate the involvement of RASI-1 in the pathology of RA, we examined synovial specimens from RA patients with antibodies directed against an unique RASI-1-derived peptide. In comparison to interstitial collagenase, gelatinase A and B, and stromelysin 1, the RASI-1 expression in the RA-synovium is located mainly in the tunica media of blood vessel walls and its synovial localization is not as ubiquitous as that of other MMPs. The tissue inhibitor of metalloproteinases (TIMP-1), although also widely expressed in the synovium, exhibits strong colocalization with RASI-1 in blood vessel walls. While RASI-1 is expressed in blood vessels of the inflamed synovium of an RA patient, its expression was not found in control synovial specimens from patients with luxation and arthrosis. However, RASI-1 expression can also be found in non-inflamed blood vessels of uterine ligaments and skin. RASI-1, although its function and substrates are unknown, could be involved in processes such as neovascularization and angiogenesis or lymphocyte extravasation and thus may participate in joint tissue destruction during RA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9232430     DOI: 10.1016/s0165-2478(97)00057-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  15 in total

1.  Characterization, expression analysis and chromosomal mapping of mouse matrix metalloproteinase-19 (MMP-19).

Authors:  J J Caterina; J Shi; C A Kozak; J A Engler; H Birkedal-Hansen
Journal:  Mol Biol Rep       Date:  2000-06       Impact factor: 2.316

Review 2.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

Review 3.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

4.  Regulation of matrix metalloproteinase expression by dynamic tensile strain in rat fibrochondrocytes.

Authors:  J Deschner; B Rath-Deschner; S Agarwal
Journal:  Osteoarthritis Cartilage       Date:  2005-11-14       Impact factor: 6.576

5.  Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.

Authors:  K Lampert; U Machein; M R Machein; W Conca; H H Peter; B Volk
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 6.  Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.

Authors:  Sugreev Verma; Kousik Kesh; Nilanjan Ganguly; Sayantan Jana; Snehasikta Swarnakar
Journal:  World J Biol Chem       Date:  2014-08-26

7.  Hepatoprotective effect of MMP-19 deficiency in a mouse model of chronic liver fibrosis.

Authors:  Marketa Jirouskova; Olga Zbodakova; Martin Gregor; Karel Chalupsky; Lenka Sarnova; Marian Hajduch; Jiri Ehrmann; Marie Jirkovska; Radislav Sedlacek
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

8.  Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.

Authors:  Rena Brauer; Inken M Beck; Martin Roderfeld; Elke Roeb; Radislav Sedlacek
Journal:  BMC Biochem       Date:  2011-07-25       Impact factor: 4.059

9.  TLR9 Deficiency in B Cells Promotes Immune Tolerance via Interleukin-10 in a Type 1 Diabetes Mouse Model.

Authors:  Sha Sha; James A Pearson; Jian Peng; Youjia Hu; Juan Huang; Yanpeng Xing; Luyao Zhang; Ying Zhu; Hongyu Zhao; F Susan Wong; Li Chen; Li Wen
Journal:  Diabetes       Date:  2020-11-05       Impact factor: 9.461

10.  MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses.

Authors:  Inken M Beck; René Rückert; Katja Brandt; Markus S Mueller; Thorsten Sadowski; Rena Brauer; Peter Schirmacher; Rolf Mentlein; Radislav Sedlacek
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.